510(k) Report

510(k) · Cleared

Cleared

NExT Station; NExT Station Advanced

K242832510(k) SpecialCleared Dec 12, 202484-day reviewClass II21 CFR 882.1835

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Eb Neuro S.P.A. · GWL Amplifier, Physiological Signal

Cleared on Dec 12, 2024 as substantially equivalent to K133517 (Eb Neuro S.P.A., 2014) and 1 other predicate after an 84-day review. Its family tree reaches back 5 generations to 2001.

Decided
Dec 12, 2024
Review
84 days
Class
Class II
Product code
GWL
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K003154 (2001). 15 ancestors in all, the oldest K870450 (1987). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2015: 1 other ancestor2008: 1 other ancestor2002: 1 other ancestor1999: 1 other ancestor1998: 1 other ancestor1993: 1 other ancestor1992: 1 other ancestor1991: 1 other ancestor1988: 1 other ancestor1987: 1 other ancestorK003154 · Mizar, Basis BE, Sandman Digital · Eb Neuro S.P.A. · 2001K041198 · NIC36 Amplifier · Eb Neuro S.P.A. · 2004K053606 · BE Plus / Aura-LTM64 Amplifier · Eb Neuro S.P.A. · 2006K121996 · BE Plus LTM Amplifier Gwi Amplifier · Eb Neuro S.P.A. · 2012K133517 · Nemus 2 System · Eb Neuro S.P.A. · 20141990200020102020
  1. Root · 5 generations backK003154 Mizar, Basis BE, Sandman DigitalEb Neuro S.P.A. · 2001
  2. 4 generations backK041198 NIC36 AmplifierEb Neuro S.P.A. · 2004
  3. 3 generations backK053606 BE Plus / Aura-LTM64 AmplifierEb Neuro S.P.A. · 2006
  4. 2 generations backK121996 BE Plus LTM Amplifier Gwi AmplifierEb Neuro S.P.A. · 2012
  5. 1 generation backK133517 Nemus 2 SystemEb Neuro S.P.A. · 2014
  6. This deviceK242832 NExT Station; NExT Station AdvancedEb Neuro S.P.A. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K003154Mizar, Basis BE, Sandman DigitalEb Neuro S.P.A.2001—
−4K041198NIC36 AmplifierEb Neuro S.P.A.2004—
−3K053606BE Plus / Aura-LTM64 AmplifierEb Neuro S.P.A.2006—
−2K121996BE Plus LTM Amplifier Gwi AmplifierEb Neuro S.P.A.2012—
−1K133517Nemus 2 SystemEb Neuro S.P.A.2014—
0 (this device)K242832NExT Station; NExT Station AdvancedEb Neuro S.P.A.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
198810
199110
199210
199310
199810
199910
200210
200810
201510
FIG. 1 — Lineage of K242832, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWL device

  1. #1 K232210 X-trodes System Mscore 10.4 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133517Nemus 2 System
Summary page 5
…OLT, IKN – EP and EMG GWE, GWF, GWJ – Auditory, Photic and Electrical stimulators Device Class: Class II Predicate Device: K133517, Nemus 2 System (Hardware, amplifier) (GWL) K142064, Galileo NT Software (OLT)…
Eb Neuro S.P.A.2014—
*K142064Galileo NT
Summary page 5
…otic and Electrical stimulators Device Class: Class II Predicate Device: K133517, Nemus 2 System (Hardware, amplifier) (GWL) K142064, Galileo NT Software (OLT) EB Neuro S.p.A. 21 CFR 882.1835 EB Neuro S.p.A.,…
Eb Neuro S.P.A.2015—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 1 company; a new generation was cleared every 3.4 years on median.
  • 1 of the 15 ancestors has a recall of any class.

How does its category compare?

All GWL devices

GWL Amplifier, Physiological Signal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · GWL

1in 2025

2007: 12009: 22010: 12011: 12012: 22014: 12015: 12017: 22018: 12020: 12021: 22022: 12023: 22024: 42025: 1
2007high 4 (2024) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWL

133in 2024

2024: 133 days median
2007high 133 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWL

1in 2013

2010: 12013: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWL

1in 2018

2008: 22018: 1
2007high 2 (2008) · low 0 (2007)2025

MAUDE reports naming product code GWL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—02
20092—00
20101—10
20111—00
20122—00
20130—10
20141—00
20151—00
20160—00
20172—00
20181—01
20190—00
20201—00
20212—00
20221—00
20232—00
2024413300
20251—00
20260—0—

What is it indicated for?

The NExT Station and NExT Station Advanced are physiological signal amplifiers intended to be used during Electromyography (EMG) and Evoked Potential (EP) exams to acquire bioelectric signals produced by the patient’s central and peripheral nervous system and muscles. The devices include Galileo NT Line software to record and display acquired data to aid the diagnosis and monitoring of potential disorders of the central and peripheral nervous system and muscles.

The devices include an electrical stimulator, an auditory stimulator, and a photic stimulator as accessories that may optionally be used in evoked response analysis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K242832: NExT Station; NExT Station Advanced.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K242832

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026